Proof of concept achieved for KB-103 as topical treatment for epidermolysis bullosa dystrophica May 17, 2019
Phase III study of abrocitinib in atopic dermatitis meets all coprimary and secondary endpoints May 15, 2019
Japanese phase III study of delgocitinib in pediatric atopic dermatitis meets primary endpoint April 26, 2019
RSS